It has been lately discovered that magnesium is vital in the activation of nerve channels that are involved in synaptic plasticity, meaning that magnesium is a critical player for the physiological events that are fundamental to the processes of learning and memory.
One form of magnesium in particular, magnesium L-threonate, has the unique ability to permeate the brain and enhance the receptors that are involved in this process. Many forms of magnesium do not effectively cross the blood brain barrier. The magnesium threonate is a chelated magnesium (similar to magnesium Glycinate) which binds the magnesium with a carrier molecule, in this case the amino acid, L-threonate. This chelation provides a form or magnesium that effectively crosses the blood brain barrier and positively impacts synapses.
As reported in the Journal, Neuron, researchers demonstrated in laboratory animals actual enhancement in the learning abilities, working memory, as well as short and long-term memory, and even quality of sleep when given magnesium magnesium threonate.
One of the most aggressively studied forms of magnesium L-threonate is a patented version by the trade name, Magteinä, developed by researchers at MIT, including a Nobel Prize winner. Their research has demonstrated actual restoration of function in aging neurons in laboratory animals. Further, it appears that Magteinä may, in fact, be the only form of magnesium that significantly increases the levels of magnesium within the brain.
Anecdotal reports in humans are showing benefits for PTSD, anxiety, and depression as well.
Magnesium is involved in over 300 biochemical processes in the body, including binding to neurotransmitter receptors and as a co-factor for neuronal enzymes. The Magnesium L-Threonate appears to be a form preferable for cognitive decline and neuron protection.
